Verrica Pharmaceuticals Inc.

NASDAQ:VRCA

Biotechnology

Healthcare
$3.14 -0.26%

-$0.02 today

Market cap
$53.94M
Beta
1.49
P/E (TTM)
-3.5
EPS (TTM)
-$1.67
52W Low $3.28High $9.82

Volume 0.10M

Average 0.08M

Balance Sheet

Inspect the capital base behind the business.

Assets

$47.13M

FY 2025 · Annual

-12.9% YoY

Liabilities

$22.39M

FY 2025 · Annual

-65.0% YoY

Equity

$24.74M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents15.75M34.27M69.55M46.33M30.15M
Short-term Investments54.6M0000
Net Receivables0487K4.42M77K5.4M
Inventory001.02M2.46M2.24M
Other Current Assets04.36M2.55M2.31M4.76M
Total Current Assets74.33M39.12M77.53M51.18M42.54M
Property, Plant & Equipment (Net)5.5M5.33M3.62M2.58M1.86M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets295K276K452K376K2.73M
Total Non-current Assets5.8M5.61M4.07M2.96M4.59M
Total Assets80.13M44.72M81.6M54.13M47.13M
Account Payables845K507K2.46M1.9M2.07M
Short-term Debt41.69M0012.94M0
Tax Payables00000
Deferred Revenue0000782K
Other Current Liabilities1.67M1.4M9.04M11.59M10.44M
Total Current Liabilities46.06M3.46M17.02M29.01M16.44M
Long-term Debt0042.87M30.98M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0002.65M5.07M
Total Non-current Liabilities1.47M1.23M44.81M34.98M5.95M
Total Liabilities47.52M4.69M61.83M63.99M22.39M
Common Stock3K4K4K9K2K
Retained Earnings(138.97M)(163.45M)(230.45M)(307.03M)(324.91M)
Accumulated OCI(29K)0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity32.61M40.03M19.76M(9.86M)24.74M
Total Debt43.41M1.53M45.51M45.94M1.63M
Net Debt27.66M(32.75M)(24.04M)(390K)(28.52M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$20.6M
Receivables$7.8M
Inventory$2.0M
Other Current$2.4M
Total Current Assets$32.8M
PP&E (Net)$1.7M
Long-term Investments$264.0K
Other Non-current$4.1M
Total Non-current Assets$6.0M
Total Assets$38.8M

Analysis

Selected assets total $38.8M for Latest. The largest visible component is Cash & Equivalents at $20.6M, about 53.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026

How much cash does VRCA have?

Verrica Pharmaceuticals Inc. (VRCA) reported $30.15M in cash and equivalents in fiscal 2025.

How much debt does VRCA carry?

Verrica Pharmaceuticals Inc. (VRCA) reported $1.63M of total debt, with net debt of -$28.52M.